Hotgen(SH:688068) Shang Hai Zheng Quan Bao·2025-12-23 20:21Core Viewpoint - Beijing Hotgen Biotech Co., Ltd. plans to sell part of its repurchased shares through centralized bidding, as the purpose of the share buyback has been achieved [2][3]. Group 1: Share Buyback Details - The company repurchased a total of 2,893,010 shares from February 8, 2024, to May 7, 2024, and has not sold or transferred any of these shares as of the announcement date [2]. - The shares will be sold within three years after the announcement of the buyback results, and any unsold shares will be canceled [2][7]. Group 2: Sale Plan - The company plans to sell up to 1,854,158 shares, which represents approximately 2% of the total share capital, within six months after the announcement [3][6]. - The sale will commence 15 trading days after the announcement, and the actual start date may be adjusted if the company's stock is suspended [6]. Group 3: Use of Proceeds - The funds from the sale will be used to supplement the company's working capital [9][11]. Group 4: Impact on Shareholding Structure - If the sale is completed, the number of shares in the repurchase account will decrease from 4,778,183 to 2,924,025, changing the holding percentage from 5.15% to 3.15% [10]. Group 5: Management's Statement - The management stated that the sale of repurchased shares will not have a significant impact on the company's operations, finances, or future development [11].